Adaptation of SARS-CoV-2 in BALB/c mice for testing vaccine efficacy
Open accessThe DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Abstract
Modeling SARS-CoV-2 in mice: Among the research tools necessary to develop medical interventions to treat severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections, high on the list are informative animal models with which to study viral pathogenesis. Gu et al. developed a mouse model in which a SARS-CoV-2 strain was infectious and could cause an inflammatory response and moderate pneumonia. Adaptation of this viral strain in the mouse appeared to be dependent on a critical amino acid change, Asn 501 to Tyr (N501Y), within the receptor-binding domain of the viral spike protein. The new mouse model was used to study neutralizing antibodies and a vaccine candidate against the virus. Science , this issue p. 1603
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Although mouse models have the most information available about their biology and many research tools, the ACE2 receptor is significantly different between mice and humans; so mouse models most often use a humanized ACE2 or lung passage to overcome this obstacle. 177-179”
From COVID-19, Myocarditis and Pericarditis (2023) · cites this paper as [179]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., Zhang, L., Fan, G., Xu, J., Gu, X., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30183-5 · Cited by 48,884
Self-citationA novel coronavirus from patients with pneumonia in China, 2019
Zhu, N., Zhang, D., Wang, W., Li, X., Yang, B., Song, J., Zhao, X., Huang, B., Shi, W., Lu, R., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2001017 · Cited by 28,244
Self-citationA pneumonia outbreak associated with a new coronavirus of probable bat origin
Zhou, P., Yang, X.-L., Wang, X.-G., Hu, B., Zhang, L., Zhang, W., Si, H.-R., Zhu, Y., Li, B., Huang, C.-L., et al. (2020) · Nature · doi:10.1038/s41586-020-2012-7 · Cited by 21,969
Self-citationDipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC
Raj, V. S., Mou, H., Smits, S. L., Dekkers, D. H. W., Müller, M. A., Dijkman, R., Muth, D., Demmers, J. A. A., Zaki, A., Fouchier, R. A. M., et al. (2013) · Nature · doi:10.1038/nature12005 · Cited by 2,061
Susceptibility of ferrets, cats, dogs, and other domesticated animals to SARS–coronavirus 2
Shi, J., Wen, Z., Zhong, G., Yang, H., Wang, C., Huang, B., Liu, R., He, X., Shuai, L., Sun, Z., et al. (2020) · Science · doi:10.1126/science.abb7015 · Cited by 1,911
The spike protein of SARS-CoV — a target for vaccine and therapeutic development
Du, L., He, Y., Zhou, Y., Liu, S., Zheng, B.-J., & Jiang, S. (2009) · Nature Reviews Microbiology · doi:10.1038/nrmicro2090 · Cited by 1,661
Self-citationTai, W., He, L., Zhang, X., Pu, J., Voronin, D., Jiang, S., Zhou, Y., & Du, L. (2020) · Cellular & Molecular Immunology · doi:10.1038/s41423-020-0400-4 · Cited by 1,654
Self-citationImmunology of COVID-19: Current State of the Science
Vabret, N., Britton, G. J., Gruber, C., Hegde, S., Kim, J., Kuksin, M., Levantovsky, R., Malle, L., Moreira, A., Park, M. D., et al. (2020) · Immunity · doi:10.1016/j.immuni.2020.05.002 · Cited by 1,623
Self-citationDevelopment of an inactivated vaccine candidate for SARS-CoV-2
Gao, Q., Bao, L., Mao, H., Wang, L., Xu, K., Yang, M., Li, Y., Zhu, L., Wang, N., Lv, Z., et al. (2020) · Science · doi:10.1126/science.abc1932 · Cited by 1,434
Self-citationCarsana, L., Sonzogni, A., Nasr, A., Rossi, R. S., Pellegrinelli, A., Zerbi, P., Rech, R., Colombo, R., Antinori, S., Corbellino, M., et al. (2020) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(20)30434-5 · Cited by 1,396
Cited by
Items 101–200 of 786
Zhang, S., Qiao, S., Yu, J., Zeng, J., Shan, S., Tian, L., Lan, J., Zhang, L., & Wang, X. (2021) · Nature Communications · doi:10.1038/s41467-021-21767-3 · Cited by 116
Self-citationTada, T., Dcosta, B. M., Samanovic-Golden, M., Herati, R. S., Cornelius, A., Mulligan, M. J., & Landau, N. R. (2021) · doi:10.1101/2021.02.05.430003 · Cited by 153
Risk of human‐to‐wildlife transmission of SARS‐CoV‐2
Gryseels, S., Bruyn, L. D., Gyselings, R., Calvignac‐Spencer, S., Leendertz, F. H., & Leirs, H. (2020) · Mammal Review · doi:10.1111/mam.12225 · Cited by 118
Variants with the N501Y mutation extend SARS-CoV-2 host range to mice, with contact transmission
Montagutelli, X., Prot, M., Levillayer, L., Salazar, E. B., Jouvion, G., Conquet, L., Beretta, M., Donati, F., Albert, M., Gambaro, F., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.03.18.436013 · Cited by 109
The Emerging Concern and Interest SARS-CoV-2 Variants
Janik, E., Niemcewicz, M., Podogrocki, M., Majsterek, I., & Bijak, M. (2021) · Pathogens · doi:10.3390/pathogens10060633 · Cited by 122
Chappell, K. J., Mordant, F. L., Li, Z., Wijesundara, D. K., Ellenberg, P., Lackenby, J. A., Cheung, S. T. M., Modhiran, N., Avumegah, M. S., Henderson, C. L., et al. (2021) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(21)00200-0 · Cited by 112
Meng, Q., Tai, W., Tian, M., Zhuang, X., Pan, Y., Lai, J., Xu, Y., Xu, Z., Li, M., Zhao, G., et al. (2023) · Science Advances · doi:10.1126/sciadv.adg3277 · Cited by 118
Self-citationAnimal models for COVID-19: advances, gaps and perspectives
Fan, C., Wu, Y., Xiong, R., Yang, Y., Ling, C., Liu, S., Liu, S., & Wang, Y. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01087-8 · Cited by 118
Self-citationRathnasinghe, R., Jangra, S., Cupic, A., Martínez-Romero, C., Mulder, L. C. F., Kehrer, T., Yildiz, S., Choi, A., Mena, I., De Vrieze, J., et al. (2021) · medRxiv · doi:10.1101/2021.01.19.21249592 · Cited by 118
Rosa, G. L., Mancini, P., Ferraro, G. B., Veneri, C., Iaconelli, M., Lucentini, L., Bonadonna, L., Brusaferro, S., Brandtner, D., Fasanella, A., et al. (2021) · Water Research · doi:10.1016/j.watres.2021.117104 · Cited by 113
Lam, S. D., Bordin, N., Waman, V. P., Scholes, H. M., Ashford, P., Sen, N., van Dorp, L., Rauer, C., Dawson, N. L., Pang, C. S. M., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-71936-5 · Cited by 113
SARS-CoV-2 evolution in animals suggests mechanisms for rapid variant selection
Bashor, L., Gagne, R. B., Bosco‐Lauth, A. M., Bowen, R. A., Stenglein, M. D., & VandeWoude, S. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2105253118 · Cited by 112
Boosting with variant-matched or historical mRNA vaccines protects against Omicron infection in mice
Ying, B., Scheaffer, S. M., Whitener, B. M., Liang, C.-Y., Dmytrenko, O., Mackin, S., Wu, K., Lee, D. W., Avena, L. E., Chong, Z., et al. (2022) · Cell · doi:10.1016/j.cell.2022.03.037 · Cited by 115
Lee, A. W. Q., Floyd, K. A., Wu, S., Fang, Z., Tan, T.-K., Froggatt, H. M., Powers, J. M., Leist, S. R., Gully, K. L., Hubbard, M. L., et al. (2023) · Nature Immunology · doi:10.1038/s41590-023-01700-0 · Cited by 108
Natural and Experimental SARS-CoV-2 Infection in Domestic and Wild Animals
Meekins, D. A., Gaudreault, N. N., & Richt, J. A. (2021) · Viruses · doi:10.3390/v13101993 · Cited by 118
Characterization and structural basis of a lethal mouse-adapted SARS-CoV-2
Sun, S., Gu, H., Cao, L., Chen, Q., Ye, Q., Yang, G., Li, R.-T., Fan, H., Deng, Y.-Q., Song, X., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-25903-x · Cited by 104
Self-citationAnimal models in SARS-CoV-2 research
Chu, H., Chan, J. F.-W., & Yuen, K.-Y. (2022) · Nature Methods · doi:10.1038/s41592-022-01447-w · Cited by 103
Susceptibility of tree shrew to SARS-CoV-2 infection
Zhao, Y., Wang, J., Kuang, D., Xu, J., Yang, M., Ma, C., Zhao, S., Li, J., Long, H., Ding, K., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-72563-w · Cited by 109
Self-citationLiu, Z., VanBlargan, L. A., Bloyet, L.-M., Rothlauf, P. W., Chen, R. E., Stumpf, S., Zhao, H., Errico, J. M., Theel, E. S., Liebeskind, M. J., et al. (2020) · doi:10.1101/2020.11.06.372037 · Cited by 135
Partial resistance of SARS-CoV-2 Delta variants to vaccine-elicited antibodies and convalescent sera
Tada, T., Zhou, H., Dcosta, B. M., Samanovic, M. I., Mulligan, M. J., & Landau, N. R. (2021) · iScience · doi:10.1016/j.isci.2021.103341 · Cited by 101
Transmission of SARS-CoV-2 in domestic cats imposes a narrow bottleneck
Braun, K. M., Moreno, G. K., Halfmann, P., Hodcroft, E. B., Baker, D. A., Boehm, E. C., Weiler, A. M., Haj, A. K., Hatta, M., Chiba, S., et al. (2021) · PLoS Pathogens · doi:10.1371/journal.ppat.1009373 · Cited by 107
Replication, pathogenicity, and transmission of SARS-CoV-2 in minks
Shuai, L., Zhong, G., Yuan, Q., Wen, Z., Wang, C., He, X., Liu, R., Wang, J., Zhao, Q., Liu, Y., et al. (2020) · National Science Review · doi:10.1093/nsr/nwaa291 · Cited by 104
Enhanced fitness of SARS-CoV-2 variant of concern Alpha but not Beta
Ulrich, L., Halwe, N. J., Taddeo, A., Ebert, N., Schön, J., Devisme, C., Trüeb, B. S., Hoffmann, B., Wider, M., Fan, X., et al. (2021) · Nature · doi:10.1038/s41586-021-04342-0 · Cited by 98
Niu, Z., Zhang, Z., Gao, X., Du, P. F., Lu, J., Yan, B., Wang, C., Zheng, Y. Y., Huang, H., & Sun, Q. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00704-2 · Cited by 98
Li, F., Han, M., Dai, P., Xu, W., He, J., Tao, X., Wu, Y., Tong, X., Xia, X., Guo, W., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-21171-x · Cited by 100
Self-citationTian, J., Sun, J., Li, D., Wang, N., Wang, L., Zhang, C., Meng, X., Ji, X., Suchard, M. A., Zhang, X., et al. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.110969 · Cited by 104
Progress and Pitfalls in the Quest for Effective SARS-CoV-2 (COVID-19) Vaccines
Flanagan, K. L., Best, E., Crawford, N. W., Giles, M., Koirala, A., Macartney, K. K., Russell, F. M., Teh, B. W., & Wen, S. C.-H. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.579250 · Cited by 103
Fratev, F. (2021) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.1c01242 · Cited by 97
Polysulfates Block SARS‐CoV‐2 Uptake through Electrostatic Interactions**
Nie, C., Pouyan, P., Lauster, D. C., Trimpert, J., Kerkhoff, Y., Szekeres, G. P., Wallert, M., Block, S., Sahoo, A. K., Dernedde, J., et al. (2021) · Angewandte Chemie International Edition · doi:10.1002/anie.202102717 · Cited by 93
Stabilized coronavirus spike stem elicits a broadly protective antibody
Hsieh, C., Werner, A. P., Leist, S. R., Stevens, L. J., Falconer, E., Goldsmith, J. A., Chou, C., Abiona, O. M., West, A., Westendorf, K., et al. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.109929 · Cited by 95
Wang, J., Shuai, L., Wang, C., Liu, R., He, X., Zhang, X., Sun, Z., Shan, D., Ge, J., Wang, X., et al. (2020) · Protein & Cell · doi:10.1007/s13238-020-00767-x · Cited by 95
Self-citationRosa, R. B., Dantas, W. M., do Nascimento, J. C. F., da Silva, M. V., de Oliveira, R. N., & Pena, L. (2021) · Viruses · doi:10.3390/v13030379 · Cited by 98
Trimpert, J., Vladimirova, D., Dietert, K., Abdelgawad, A., Kunec, D., Dökel, S., Voß, A., Gruber, A. D., Bertzbach, L. D., & Osterrieder, N. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.108488 · Cited by 93
Kumar, M., Gulati, S., Ansari, A. H., Phutela, R., Acharya, S., Azhar, M., Murthy, J., Kathpalia, P., Kanakan, A., Maurya, R., et al. (2021) · eLife · doi:10.7554/elife.67130 · Cited by 90
Ning, Q., Wu, D., Wang, X., Xi, D., Chen, T., Chen, G., Wang, H., Lü, H., Wang, M., Zhu, L., et al. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-00907-1 · Cited by 91
Self-citationProtective activity of mRNA vaccines against ancestral and variant SARS-CoV-2 strains
Ying, B., Whitener, B., VanBlargan, L. A., Hassan, A. O., Shrihari, S., Liang, C.-Y., Karl, C. E., Mackin, S., Chen, R. E., Kafai, N. M., et al. (2022) · Science Translational Medicine · doi:10.1126/scitranslmed.abm3302 · Cited by 85
Batty, C. J., Heise, M. T., Bachelder, E. M., & Ainslie, K. M. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.12.006 · Cited by 81
Wu, M., Liu, F., Sun, J., Li, X., He, X.-Y., Zheng, H., Pei, R., Sun, H., Zhou, Y.-H., Yan, Q., et al. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00849-0 · Cited by 89
Self-citationOrigin and evolution of SARS-CoV-2
Pagani, I., Ghezzi, S., Alberti, S., Poli, G., & Vicenzi, E. (2023) · The European Physical Journal Plus · doi:10.1140/epjp/s13360-023-03719-6 · Cited by 96
Silva-Cayetano, A., Foster, W. S., Innocentin, S., Belij-Rammerstorfer, S., Spencer, A. J., Burton, O. T., Fra-Bidó, S., Le Lee, J., Thakur, N., Conceicao, C., et al. (2021) · Med · doi:10.1016/j.medj.2020.12.006 · Cited by 84
Liu, H., Bai, Y., Zhang, X., Gao, T., Liu, Y., Li, E., Wang, X., Cao, Z., Zhu, L., Dong, Q., et al. (2022) · Journal of Virology · doi:10.1128/jvi.00412-22 · Cited by 91
Self-citationA Comprehensive Review of Animal Models for Coronaviruses: SARS-CoV-2, SARS-CoV, and MERS-CoV
Singh, A. K., Singh, R. S., Sarma, P., Batra, G., Joshi, R., Kaur, H., Sharma, A. R., Prakash, A., & Medhi, B. (2020) · Virologica Sinica · doi:10.1007/s12250-020-00252-z · Cited by 84
Wang, W. B., Liang, Y., Jin, Y. Q., Zhang, J., Su, J. G., & Li, Q. M. (2021) · Journal of Molecular Graphics and Modelling · doi:10.1016/j.jmgm.2021.108035 · Cited by 90
Liu, H., Wei, P., Kappler, J. W., Marrack, P., & Zhang, G. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.825256 · Cited by 98
Ferrareze, P. A. G., Franceschi, V. B., Mayer, A. D. M., Caldana, G. D., Zimerman, R. A., & Thompson, C. E. (2021) · Infection, Genetics and Evolution · doi:10.1016/j.meegid.2021.104941 · Cited by 82
Animal models for SARS‐CoV‐2 research: A comprehensive literature review
Pandey, K., Acharya, A., Mohan, M., Ng, C. L., Reid, S. P., & Byrareddy, S. N. (2020) · Transboundary and Emerging Diseases · doi:10.1111/tbed.13907 · Cited by 86
Makowski, L., Olson-Sidford, W., & Weisel, J. W. (2021) · Viruses · doi:10.3390/v13020146 · Cited by 88
Tackling COVID-19 with neutralizing monoclonal antibodies
Corti, D., Purcell, L. A., Snell, G., & Veesler, D. (2021) · Cell · doi:10.1016/j.cell.2021.07.027 · Cited by 78
“…shown to increase by 6-fold the affinity for human ACE2 (Collier et al., 2021) and was also associated to an increased interaction withmurine ACE2 (Gu et al., 2020), raising the possibility thatmutations in S may also emerge as a result of inter-species exchange of SARS-CoV-2, like the two-way…”
SARS-CoV-2 Causes Lung Infection without Severe Disease in Human ACE2 Knock-In Mice
Winkler, E. S., Chen, R. E., Alam, F., Yildiz, S., Case, J. B., Uccellini, M. B., Holtzman, M. J., García‐Sastre, A., Schotsaert, M., & Diamond, M. (2021) · Journal of Virology · doi:10.1128/jvi.01511-21 · Cited by 80
Organ-specific genome diversity of replication-competent SARS-CoV-2
Cleemput, J. V., van Snippenberg, W., Lambrechts, L., Dendooven, A., D’Onofrio, V., Couck, L., Trypsteen, W., Vanrusselt, J., Theuns, S., Vereecke, N., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-26884-7 · Cited by 79
Characterization of a new SARS-CoV-2 variant that emerged in Brazil
Imai, M., Halfmann, P., Yamayoshi, S., Iwatsuki‐Horimoto, K., Chiba, S., Watanabe, T., Nakajima, N., Ito, M., Kuroda, M., Kiso, M., et al. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2106535118 · Cited by 83
Mouse-adapted SARS-CoV-2 protects animals from lethal SARS-CoV challenge
Muruato, A., Vu, M. N., Johnson, B. A., Davis-Gardner, M. E., Vanderheiden, A., Lokugamage, K., Schindewolf, C., Crocquet-Valdes, P. A., Langsjoen, R. M., Plante, J. A., et al. (2021) · PLOS Biology · doi:10.1371/journal.pbio.3001284 · Cited by 82
A defective viral genome strategy elicits broad protective immunity against respiratory viruses
Xiao, Y., Lidsky, P. V., Shirogane, Y., Aviner, R., Wu, C.-T., Li, W., Zheng, W., Talbot, D., Catching, A., Doitsh, G., et al. (2021) · Cell · doi:10.1016/j.cell.2021.11.023 · Cited by 83
SARS-CoV-2 infection of sustentacular cells disrupts olfactory signaling pathways
Verma, A. K., Zheng, J. H., Meyerholz, D. K., & Perlman, S. M. (2022) · JCI Insight · doi:10.1172/jci.insight.160277 · Cited by 79
Haabeth, O. A. W., Lohmeyer, J. J. K., Sallets, A., Blake, T. R., Sagiv-Barfi, I., Czerwinski, D. K., McCarthy, B., Powell, A. E., Wender, P. A., Waymouth, R. M., et al. (2021) · ACS Central Science · doi:10.1021/acscentsci.1c00361 · Cited by 77
Ren, W., Lan, J., Ju, X., Gong, M., Long, Q., Zhu, Z., Yu, Y., Wu, J., Zhong, J., Zhang, R., et al. (2021) · PLoS Pathogens · doi:10.1371/journal.ppat.1010053 · Cited by 76
Self-citationCase, J. B., Chen, R. E., Cao, L., Ying, B., Winkler, E. S., Johnson, M., Goreshnik, I., Pham, M. N., Shrihari, S., Kafai, N. M., et al. (2021) · Cell Host & Microbe · doi:10.1016/j.chom.2021.06.008 · Cited by 73
“…the efficacy of LCB1-Fc in a non-transgenic 129S2mousemodel of SARS-CoV-2 infection with two strains containing the mouse-adapting N501Y substitution (Gu et al., 2020; Rathnasinghe et al., 2021): a recombinant WA1/2020 strain containing N501Y and D614G substitutions and a B.1.1.7 natural isolate.”
BackgroundMethodInfluentialPan, T. S., Chen, R., He, X., Yuan, Y., Deng, X., Li, R., Yan, H., Yan, S., Liu, J., Zhang, Y., et al. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00848-1 · Cited by 75
Lee, C.-Y., & Lowen, A. C. (2021) · Current Opinion in Virology · doi:10.1016/j.coviro.2021.03.009 · Cited by 76
Yi, C., Sun, X., Lin, Y., Gu, C., Ding, L., Lü, X., Yang, Z., Zhang, Y., Ma, L., Gu, W., et al. (2021) · Genome Medicine · doi:10.1186/s13073-021-00985-w · Cited by 76
Self-citationDynamics of SARS-CoV-2 Spike Proteins in Cell Entry: Control Elements in the Amino-Terminal Domains
Qing, E., Kicmal, T., Kumar, B., Hawkins, G. M., Timm, E. C., Perlman, S. M., & Gallagher, T. (2021) · mBio · doi:10.1128/mbio.01590-21 · Cited by 71
Tarrés-Freixas, F., Trinité, B., Pons-Grífols, A., Romero‐Durana, M., Riveira‐Muñoz, E., Ávila‐Nieto, C., Pérez, M., García-Vidal, E., Perez‐Zsolt, D., Muñoz‐Basagoiti, J., et al. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.840757 · Cited by 73
Sun, S., He, L., Zhao, Z., Gu, H., Fang, X. D., Wang, T., Yang, X., Chen, S., Deng, Y., Li, J., et al. (2021) · Cellular and Molecular Immunology · doi:10.1038/s41423-021-00658-z · Cited by 68
Self-citationA proof of concept for neutralizing antibody-guided vaccine design against SARS-CoV-2
Zhang, L., Cao, L., Gao, X., Zheng, B., Deng, Y., Li, J., Feng, R., Bian, Q., Guo, X., Wang, N., et al. (2021) · National Science Review · doi:10.1093/nsr/nwab053 · Cited by 75
Self-citationFratev, F. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.12.23.424283 · Cited by 70
CCR2 Signaling Restricts SARS-CoV-2 Infection
Vanderheiden, A., Thomas, J., Soung, A. L., Davis-Gardner, M. E., Floyd, K. A., Jin, F., Cowan, D. A., Pellegrini, K., Creanga, A., Pegu, A., et al. (2021) · mBio · doi:10.1128/mbio.02749-21 · Cited by 70
Fred, S. M., Kuivanen, S. H., Uğurlu, H., Casarotto, P. C., Levanov, L., Saksela, K., Vapalahti, O., & Ċastrén, E. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.755600 · Cited by 71
TMPRSS2 Is Essential for SARS-CoV-2 Beta and Omicron Infection
Metzdorf, K., Jacobsen, H., Greweling‐Pils, M. C., Hoffmann, M., Lüddecke, T., Miller, F., Melcher, L., Kempf, A. M., Nehlmeier, I., Bruder, D., et al. (2023) · Viruses · doi:10.3390/v15020271 · Cited by 70
One year into the pandemic: Short-term evolution of SARS-CoV-2 and emergence of new lineages
Gónzález‐Candelas, F., Shaw, M., Phan, T. G., Kulkarni‐Kale, U., Paraskevis, D. N., Luciani, F., Kimura, H., & Sironi, M. (2021) · Infection Genetics and Evolution · doi:10.1016/j.meegid.2021.104869 · Cited by 69
Zoonotic and Reverse Zoonotic Transmissibility of SARS-CoV-2
Goraichuk, I. V., Arefiev, V. L., Stegniy, B. Т., & Gerilovych, A. (2021) · Virus Research · doi:10.1016/j.virusres.2021.198473 · Cited by 73
Mutations that adapt SARS-CoV-2 to mink or ferret do not increase fitness in the human airway
Zhou, J., Peacock, T. P., Brown, J. C., Goldhill, D. H., Elrefaey, A. M. E., Penrice-Randal, R., Cowton, V. M., De Lorenzo, G., Furnon, W., Harvey, W. T., et al. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.110344 · Cited by 64
“For example, mice are inefficiently infected by early SARS-CoV-2 isolates unless they are engineered to transgeni-cally express human ACE2, or SARS-CoV-2 is adapted to murine ACE2 by serial mouse passage (Gu et al., 2020; Rathnasinghe et al., 2021).”
Tada, T., Zhou, H., Dcosta, B. M., Samanovic, M. I., Mulligan, M. J., & Landau, N. R. (2021) · doi:10.1101/2021.05.14.444076 · Cited by 101
“7 results in increased affinity 55 for ACE2 [7-10] while the E484K mutation in the B.”
GP73 is a glucogenic hormone contributing to SARS-CoV-2-induced hyperglycemia
Wan, L., Gao, Q., Deng, Y., Ke, Y., Ma, E., Yang, H., Lin, H., Li, H., Yang, Y., Gong, J., et al. (2022) · Nature Metabolism · doi:10.1038/s42255-021-00508-2 · Cited by 64
Self-citationDevelopment and preclinical evaluation of virus‐like particle vaccine against COVID‐19 infection
Yilmaz, I. C., İpekoğlu, E. M., Bulbul, A., Turay, N., Yıldırım, M., Evcili, İ., Yilmaz, N. S., Guvencli, N., Aydin, Y., Gungor, B., et al. (2021) · Allergy · doi:10.1111/all.15091 · Cited by 66
SARS-CoV-2 Variants and Their Relevant Mutational Profiles: Update Summer 2021
Alkhatib, M., Svicher, V., Salpini, R., Ambrosio, F. A., Bellocchi, M. C., Carioti, L., Piermatteo, L., Scutari, R., Costa, G., Artese, A., et al. (2021) · Microbiology Spectrum · doi:10.1128/spectrum.01096-21 · Cited by 65
Iwata‐Yoshikawa, N., Shiwa, N., Sekizuka, T., Sano, K., Ainai, A., Hemmi, T., Kataoka, M., Kuroda, M., Hasegawa, H., Suzuki, T., et al. (2022) · Science Advances · doi:10.1126/sciadv.abh3827 · Cited by 70
Transmission of SARS-CoV-2 from humans to animals and potential host adaptation
Tan, C. C. S., Lam, S. D., Richard, D., Owen, C., Berchtold, D., Orengo, C., Nair, M. S., Kuchipudi, S. V., Kapur, V., van Dorp, L., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.11.16.384743 · Cited by 60
Gawish, R., Starkl, P. M., Pimenov, L., Hladik, A., Lakovits, K., Oberndorfer, F., Cronin, S. J., Ohradanova‐Repic, A., Wirnsberger, G., Agerer, B., et al. (2022) · eLife · doi:10.7554/elife.74623 · Cited by 67
Zhou, Q., Gu, H., Sun, S., Zhang, Y., Hou, Y., Li, C., Zhao, Y., Ma, P., Lv, L., Aji, S., et al. (2021) · Advanced Materials · doi:10.1002/adma.202102528 · Cited by 61
Self-citationTada, T., Dcosta, B. M., Zhou, H., Vaill, A., Kazmierski, W., & Landau, N. R. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.02.18.431897 · Cited by 63
Increased infections, but not viral burden, with a new SARS-CoV-2 variant
Walker, A. S., Vihta, K.-D., Gethings, O., Pritchard, E., Jones, J., House, T., Bell, I., Bell, J. I., Newton, J. N., Farrar, J., et al. (2021) · doi:10.1101/2021.01.13.21249721 · Cited by 58
TRIM28-mediated nucleocapsid protein SUMOylation enhances SARS-CoV-2 virulence
Ren, J., Wang, S., Zong, Z., Pan, T. S., Liu, S., Mao, W., Huang, H., Yan, X., Yang, B., He, X., et al. (2024) · Nature Communications · doi:10.1038/s41467-023-44502-6 · Cited by 69
Khadangi, F., Forgues, A.-S., Tremblay-Pitre, S., Dufour-Mailhot, A., Henry, C., Boucher, M., Beaulieu, M., Morissette, M. C., Fereydoonzad, L., Brunet, D., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-87462-x · Cited by 64
Treatment of SARS-CoV-2-induced pneumonia with NAD+ and NMN in two mouse models
Jiang, Y., Deng, Y., Pang, H., Ma, T., Ye, Q., Chen, Q., Chen, H., Hu, Z., Qin, C., & Xu, Z. (2022) · Cell Discovery · doi:10.1038/s41421-022-00409-y · Cited by 59
Self-citationDifferential Pathogenesis of SARS-CoV-2 Variants of Concern in Human ACE2-Expressing Mice
Natekar, J. P., Pathak, H., Stone, S., Kumari, P., Sharma, S., Auroni, T. T., Arora, K., Rothan, H. A., & Kumar, M. (2022) · Viruses · doi:10.3390/v14061139 · Cited by 54
Preclinical evaluation of a SARS-CoV-2 mRNA vaccine PTX-COVID19-B
Liu, J., Budylowski, P., Samson, R., Griffin, B. D., Babuadze, G., Rathod, B., Colwill, K., Abioye, J. A., Schwartz, J. A., Law, R., et al. (2022) · Science Advances · doi:10.1126/sciadv.abj9815 · Cited by 56
Wilton, T., Bujáki, E., Klapsa, D., Majumdar, M., Zambon, M. C. F. A., Fritzsche, M., Mate, R., & Martín, J. E.-S. (2021) · mSystems · doi:10.1128/msystems.00353-21 · Cited by 61
Covid-19: virology, variants, and vaccines
Young, M., Crook, H., Scott, J. T., & Edison, P. (2022) · BMJ Medicine · doi:10.1136/bmjmed-2021-000040 · Cited by 64
Understanding the Secret of SARS-CoV-2 Variants of Concern/Interest and Immune Escape
Lou, F., Li, M., Pang, Z., Jiang, L., Guan, L., Tian, L., Hu, J., Fan, J., & Fan, H. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.744242 · Cited by 58
Self-citationAge-dependent pathogenic characteristics of SARS-CoV-2 infection in ferrets
Kim, Y., Yu, K.-M., Koh, J., Kim, E.-H., Kim, S., Kim, E. J., Casel, M. A. B., Rollon, R., Jang, S., Song, M., et al. (2022) · Nature Communications · doi:10.1038/s41467-021-27717-3 · Cited by 57
Mechanisms of SARS‐CoV‐2‐induced lung vascular disease: potential role of complement
Stenmark, K. R., Frid, M. G., Gerasimovskaya, E. V., Zhang, H., McCarthy, M. K., Thurman, J. M., & Morrison, T. E. (2021) · Pulmonary Circulation · doi:10.1177/20458940211015799 · Cited by 60
Mechanisms of Lung Injury Induced by SARS-CoV-2 Infection
Upadhya, S. W., Rehman, J., Malik, A. B., & Chen, S. (2021) · Physiology · doi:10.1152/physiol.00033.2021 · Cited by 60
Self-citationThe way of SARS-CoV-2 vaccine development: success and challenges
Dong, Y., Dai, T., Wang, B., Zhang, L., Zeng, L., Huang, J., Yan, H., Zhang, L., & Zhou, F. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00796-w · Cited by 58
The molecular basis for SARS-CoV-2 binding to dog ACE2
Zhang, Z., Zhang, Y., Liu, K., Li, Y., Lu, Q., Wang, Q., Zhang, Y., Wang, L., Liao, H., Zheng, A., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-24326-y · Cited by 56
Self-citationKidney injury in COVID-19 patients, drug development and their renal complications: Review study
Yarijani, Z. M., & Najafi, H. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.111966 · Cited by 56
Dominance of Alpha and Iota variants in SARS-CoV-2 vaccine breakthrough infections in New York City
Duerr, R., Dimartino, D., Marier, C., Zappile, P., Wang, G., Lighter, J., Elbel, B. D., Troxel, A. B., & Heguy, A. (2021) · Journal of Clinical Investigation · doi:10.1172/jci152702 · Cited by 56
Impaired immune response drives age-dependent severity of COVID-19
Beer, J., Crotta, S., Breithaupt, A., Ohnemus, A., Becker, J., Sachs, B., Kern, L., Llorian, M., Ebert, N., Labroussaa, F., et al. (2022) · The Journal of Experimental Medicine · doi:10.1084/jem.20220621 · Cited by 53
Kiener, M., Roldán, N., Machahua, C., Sengupta, A., Geiser, T., Guenat, O. T., Funke-Chambour, M., Hobi, N., & Julio, M. K. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.644678 · Cited by 54
Rational development of a combined mRNA vaccine against COVID-19 and influenza
Ye, Q., Wu, M., Chao Hui, Z. H. O. U., Lu, X., Huang, B., Zhang, N., Zhao, H. J., Chi, H., Zhang, X., Ling, D., et al. (2022) · npj Vaccines · doi:10.1038/s41541-022-00478-w · Cited by 54
Self-citationShuai, H., Chan, J. F., Hu, B., Chai, Y., Yoon, C., Liu, H., Liu, Y., Shi, J., Zhu, T., Hu, J., et al. (2023) · EBioMedicine · doi:10.1016/j.ebiom.2023.104753 · Cited by 53
Self-citation
Metadata
- Authors
- Gu, H., Chen, Q., Yang, G., He, L., Fan, H., Deng, Y.-Q., Wang, Y., Teng, Y., Zhao, Z., Cui, Y., Li, Y., Li, X.-F., Li, J., Zhang, N.-N., Yang, X., Chen, S., Guo, Y., Zhao, G., Wang, X., Luo, D.-Y., Wang, H., Yang, X., Li, Y., Han, G., He, Y., Zhou, X., Geng, S., Sheng, X., Jiang, S., Sun, S., Qin, C.-F., & Zhou, Y.
- Affiliations
- Academy of Military Medical Sciences (CN)
- Beijing Proteome Research Center (CN)
- State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Academy of Military Medical Sciences, Beijing 100071, China.
- Institute of Military Cognition and Brain Sciences, Beijing 100850, China.
- Chinese Academy of Medical Sciences & Peking Union Medical College (CN)
- Beijing JOINN Biologics Co., Beijing 100176, China.
- Shanghai Medical College of Fudan University (CN)
- Corresponding author
- Gu, Hongjing
- Chen, Qi
- Yang, Guan
- He, Lei
- Fan, Hang
- Deng, Yong-Qiang
- Jiang, Shibo
- Sun, Shihui
- Qin, Cheng-Feng
- Zhou, Yusen
- ORCID
- Gu, Hongjing
- Chen, Qi
- Yang, Guan
- He, Lei
- Fan, Hang
- Deng, Yong-Qiang
- Wang, Yanxiao
- Teng, Yue
- Zhao, Zhongpeng
- Cui, Yujun
- Li, Yuchang
- Li, Xiao-Feng
- Li, Jiangfan
- Zhang, Na-Na
- Yang, Xiaolan
- Chen, Shaolong
- Guo, Yan
- Zhao, Guangyu
- Wang, Xiliang
- Wang, Hui
- Yang, Xiao
- Li, Yan
- Han, Gencheng
- He, Yuxian
- Zhou, Xiaojun
- Jiang, Shibo
- Sun, Shihui
- Qin, Cheng-Feng
- Zhou, Yusen
- Venue
- Science
- Published
- 2020-09-25
- Volume
- 369
- Issue
- 6511
- Pages
- 1603-1607
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- PMC
- PMC7574913
- OpenAlex
- W3045870925
- Cited by
- 762
- References
- 30
- Citations by year
- 2026: 20 · 2025: 36 · 2024: 66 · 2023: 82 · 2022: 194 · 2021: 321 · 2020: 42
- FWCI
- 21.13
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Science (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- National Natural Science Foundation of China (82041006, 82041025)
- National Science Fund for Distinguished Young Scholars (81925025)
- National Science and Technology Major Project of China (2018ZX09711003, 2017ZX10304402)
- Beijing Municipal Science and Technology Project (201100001020004)
- National Key Plan for Scientific Research and Development of China (2016YFD0500304, 2016YFD0500306, 2020YFA0707801)
- Innovation Fund for Medical Sciences of the Chinese Academy of Medical Sciences. (2019-I2M-5-049)
- Topics
- Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
- Life Sciences › Agricultural and Biological Sciences › Animal Science and Zoology › Animal Virus Infections Studies
- Health Sciences › Medicine › Infectious Diseases › COVID-19 Clinical Research Studies
- Keywords
- SARS-CoV-2, BALB/c mice, vaccine efficacy, serial passage, N501Y mutation, spike protein receptor-binding domain, interstitial lung disease, aged mice, challenge model, adaptive mutation, viral virulence
- MeSH terms
- Immunogenicity, Vaccine, Betacoronavirus, Angiotensin-Converting Enzyme 2, COVID-19, SARS-CoV-2, COVID-19 Vaccines, Administration, Intranasal, Animals, Disease Models, Animal, Female, Humans, Peptidyl-Dipeptidase A, Lung, Mice, Inbred BALB C, Mice, Transgenic, Mutation, Pneumonia, Viral, Vaccines, Synthetic, Viral Vaccines, Virulence, Lung Diseases, Interstitial, Coronavirus Infections, Mice, Pandemics, High-Throughput Nucleotide Sequencing, Spike Glycoprotein, Coronavirus
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.